Enzictra Ds Strip Of 6 Tablets
6 Tablet(s) in StripMRP ₹430.00
₹301.00
30% OFF
Made by
ALEMBIC PHARMACEUTICALS LTD
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Bromelain(180.0 Mg)+Rutoside(200.0 Mg)+Trypsin(96.0 Mg)+Papain(120.0 Mg) |
| Therapy | Anti-inflammatory, analgesic |
Assurance
available
Regulated
Medical Description
Uses
Contraindications
- If you are allergic to Bromelain, Trypsin, Rutoside, Papain or any other component of Enzictra-DS Tablet.
- If you have a blood disorder such as haemophilia, clotting disorder or liver disorder.
- If you have a kidney disorder and are undergoing haemodialysis.
- If you any infection.
Side effects
- Stomach bloating
- Flatulence
- Nausea
- Vomiting
- Dark-coloured stools
- Diarrhoea
- Dizziness
- Rash, itching
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have liver or kidney disease.
- You are pregnant.
- You have or had any medical condition and are on medication.
- You experience any side effect after taking Enzictra-DS Tablet.
Directions for Use
Storage and disposal
- Store at temperature below 30°C in a cool, dry place.
- Keep it out of the reach of children and pets.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
- Trypsin, Papain and Bromelain have anti-inflammatory properties. It acts by increasing the blood supply to the affected area. Thus, reducing the pain and swelling. It also decreases the movement to inflammatory cells, enhancing the healing process respectively.
- Rutoside has an antioxidant and anti-platelet aggregation property, which prevents the formation of free radical thus prevents cell damage and avoids gathering of the platelets, further improving blood circulation and fastens the wound healing.
Interactions
Interactions with other medicines
- Medicines used as a blood thinner such as warfarin should be used with caution, as it can cause an increased risk of bleeding when used along with Enzictra-DS Tablet.
- Enzictra-DS Tablet may alter the effect of antibiotics such as amoxicillin when used concomitantly.
- Discuss with your doctor about any other medicines, herbal preparations and supplements you are taking currently to avoid any possible interactions.
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ENZICTRA
Manufacturer Name:ALEMBIC PHARMACEUTICALS LTD
Address:<p>1. Alembic Road, Vadodara - 390 003, Gujarat,INDIA</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Enzictra Ds Strip Of 6 Tablets will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.



















